IV Vitamin C and Breast Cancer: What You Need to Know
Subscribe to be notified when new articles are published. You’ll also receive my 2 free ebooks to assist you on your journey.
My subscribers also get a treasure trove of info on nutrition, supplements and lifestyle tips on surviving breast cancer.
IV Vitamin C and Breast Cancer: What You Need to Know
IV vitamin C therapy has long been popular as a complementary approach in breast cancer care. While not considered a replacement for conventional treatment, many alternative cancer clinics employ intravenous (IV) vitamin C to support the health of their cancer patients. In this article, I will unpack what IV vitamin C therapy is, its benefits, and what breast cancer patients should consider before adding it to their wellness routine.
Ever since 1976 when Dr Linus Pauling began advocating the use of IV vitamin C in the fight against cancer, this has been a controversial subject because proving that it works has been troublesome.
Holistic cancer clinics have employed IV vitamin C for cancer patients for decades.
However, clinical trials have had mixed results, with some small trials showing a benefit in terms of few side effects and a synergistic effect between the IV vitamin C and conventional therapies like radiation and chemotherapy, but not as a stand-alone therapy to regress tumors.
Many of my clients have utilized IV vitamin C in their wellness journey, with good effect. No one, to my knowledge, however, used it on its own to help them get well – it has always been one part of a healing regimen which also included many other therapies, both conventional and natural.
Having said all of that, if IV vitamin C therapy wasn’t getting good results for cancer patients, no doubt the practice would have been discontinued long ago. Kind of like shark cartilage (anyone remember that?). But that isn’t the case, and in fact, a brand new 2025 review of preclinical and clinical studies [1] gives us a much-deeper look at IV vitamin C treatments in the management of cancer.
The authors of the review called IV vitamin C a “promising anti-tumor agent”, stating “vitamin C has reemerged as a promising anti-cancer therapy in the form of high-dose administration…” [1]
The Mechanism of Action of Intravenous Vitamin C
Probably everyone has heard of vitamin C, also known as ascorbic acid. It is an essential nutrient that plays a crucial role in human physiology. We cannot make it ourselves – we lack the key enzyme (L-gulonolactone oxidase) required for the final step of the synthesis of vitamin C, so we must obtain it from dietary sources to meet our physiological needs for vitamin C.
When mega-doses of vitamin C are given intravenously – directly into the bloodstream – this allows the vitamin C to reach ultra-high levels, much higher than when the same amount is taken by mouth.
Depending on the concentration of vitamin C and its method of administration, it exhibits both antioxidant and pro-oxidant properties. [2] At low concentrations, vitamin C acts primarily as an antioxidant, eradicating free radicals and protecting healthy cells. At high concentrations, however, it displays pro-oxidant characteristics, inducing oxidative stress in cells, particularly within the tumor microenvironment, where it exerts anti-tumor effects.
It induces the production of reactive oxygen species (ROS), and that has a cytotoxic effect on tumor cells.
Interestingly, the selective toxicity of vitamin C in tumors is linked to iron metabolism. Tumor cells have a significantly higher dependence on iron compared with normal cells. An accumulation of iron has a pivotal role in the initiation and progression of a tumor, as well as drug resistance, and immune evasion.
A 2010 study [3] found that breast cancer cells have approximately twice the level of iron than normal breast epithelial cells. That’s important because it is this dependency on iron by tumor cells that provides a potential target for the pro-oxidant activity of vitamin C. High concentrations of vitamin C is known to react with iron ions to generate hydrogen peroxide. It is the production of these hydroxyl radicals that induce DNA damage and disrupt the integrity of tumor cell membranes, ultimately leading to tumor cell death. That’s one method of action of IV vitamin C.
Another method of action has to do with glucose. Tumor cells have an enhanced uptake of glucose in what is termed the Warburg Effect. Cancer cells behave differently from normal cells — they use a fast-burning, sugar-heavy energy process called glycolysis. This makes them absorb more glucose and, interestingly, more vitamin C too. [1]
In particular, cancer cells with certain mutations (like KRAS or BRAF) are especially hungry for sugar and have more “doors” (called transporters) that let both glucose and vitamin C into the cell. Once inside, the oxidized form of vitamin C (called DHA) gets converted back to its active form, but this process uses up important cellular resources. It drains antioxidants like glutathione and NADPH, which normally protect the cell from stress. Without these defenses, the cancer cell builds up damaging molecules known as reactive oxygen species and loses its ability to make energy — leading to cell death. Normal cells can handle this stress and stay balanced. But cancer cells with KRAS or BRAF mutations can’t cope. That’s why high-dose IV vitamin C can selectively weaken and kill these cancer cells without harming healthy ones. [1]
A third way that IV vitamin C works against cancer has to do with its effects on certain genes. It has been shown to promote tumor suppressor genes, activate protective proteins, suppress oncogenes (genes associated with the development of cancer), and quiet genes associated with inflammation. [1]
In summary IV vitamin C has these effects:
* In healthy cells, it is an antioxidant and is protective. Against cancer cells, it acts as a pro-oxidant (it promotes oxidative stress and is cytotoxic)
* Inhibits angiogenesis, the ability of a tumor to create its own blood vessels with which to feed itself
* Is an epigenetic regulator – it upregulates (promotes) tumor suppressor genes, activates protective proteins, down-regulates (suppresses) oncogenes, down-regulates genes associated with inflammation
* Increases tumor sensitivity to chemotherapy, radiation, targeted therapy and immunotherapy
* Mitigates the toxic side-effects of chemotherapy and radiation
* Improves the quality of life in patients with advanced cancer, corrects deficiencies in vitamin C that often occur in these patients
* Enhances the anti-tumor capabilities of immune cells – it profoundly affects immune cell metabolism and function
IV Vitamin C Studies
As I mentioned earlier, vitamin C has been examined for decades for possible anticancer activity. As long ago as 1959, WJ McCormick reported the potential anti-tumor effects of vitamin C. [4]
Since then, vitamin C has garnered significant interest as an anticancer agent. In the 1970s, Ewan Cameron and Linus Pauling conducted studies showing that high-dose vitamin C supplementation could alleviate symptoms and prolong survival in advanced cancer patients. [5], [6]
However, two subsequent rigorous clinical trials by Dr Edward Creagan and Dr Charles Moertel [7] [8] failed to confirm what Cameron and Pauling found. This had everyone puzzled. This inconsistency in research led to some rather intense debates, and because Creagan’s study was a double-blind prospective study, the prevailing view was that high dose vitamin C therapy had no significant impact on cancer survival outcomes.
There was a reason for that, though. More recent advancements in the pharmacokinetics of vitamin C have given us a new insight into the discrepancies of those older trials. We now understand that plasma concentrations of vitamin C taken orally are strictly controlled by (a) the ability of the gastrointestinal system to absorb it, (b) the presence of tissue transport proteins, and (c) the ability of the kidneys to reabsorb and excrete it.
As a result, we now know that vitamin C taken orally can only achieve a certain concentration in plasma, whereas vitamin C administered intravenously is much more effective, bypassing these regulatory mechanisms of the body. As a result, IV vitamin C has once again gained attention as a potential cancer therapy.
A number of in vitro (test tube) preclinical studies have shown that pharmacological concentrations of vitamin C exhibit cancer-killing effect against various tumor cell lines while having no significant impact on normal cells. [9] [10] [11]
We also have a number of animal studies which show that IV vitamin C can significantly inhibit the occurrence and development of certain cancers [12] [13] [14]
But does that extrapolate to humans?
Most clinical trials conducted to date have only involved a small number of patients. We need more large-scale, high-quality randomized controlled trials are needed to further evaluate the anti-tumor effects of IV vitamin C. We currently have multiple preclinical studies which have demonstrated the potential benefits of combining IV vitamin C with existing conventional treatments such as chemotherapy and radiotherapy, enhancing their therapeutic effects while reducing side effects.
A 2010 article investigated the use of IV vitamin C by complementary and alternative medicine practitioners, gathering information on its use and tolerance in patients. The researchers concluded “High dose IV vitamin C is in unexpectedly wide use by CAM practitioners. Other than the known complications of IV vitamin C in those with renal impairment or glucose 6 phosphate dehydrogenase deficiency, high dose intravenous vitamin C appears to be remarkably safe. Physicians should inquire about IV vitamin C use in patients with cancer, chronic, untreatable, or intractable conditions and be observant of unexpected harm, drug interactions, or benefit.” [15]
Clinical trials investigating the effects of IV vitamin C as a stand-alone cancer treatment have yielded conflicting results. And of course, when anticipating performing clinical trials with actual human beings we raise ethical concerns over the well-being of patients in such trials who are only given IV vitamin C and no other conventional treatments such as chemotherapy and/or radiation. So clinical trials are fairly thin on the ground. Many clinics, I have found, advise their patients to combine IV vitamin C with conventional cancer therapies like chemotherapy and radiation.
Here are some of the more interesting clinical trials I found.
A small phase 1 clinical trial reported in 2008 [16] involved 18 patients with advanced cancer who were given varying doses of IV vitamin C. Not one patient had an antitumor response but study authors noted the therapy was “well-tolerated”.
One small 2016 Singaporean study [17] with only 9 patients with various stages of cancer indicated IV vitamin C had minimal side effects and showed “promising results”.
A slightly larger 2013 study [18] with 15 patients of only one month’s duration found that the IV vitamin C doses were well tolerated but that no patient demonstrated an objective antitumor response. It’s important to note that most clinics recommend IV vitamin C for a duration longer than one month for their cancer patients. See below for more information on this.
A 2011 German study [19] with 125 breast cancer patients who were stages Iia to IIIb found that IV vitamin C administration resulted in a significant reduction of health complaints, in particular of nausea, fatigue, loss of appetite, sleep disturbances, depression, dizziness and bleeding/bruising.
In a 2014 clinical trial researchers at the University of Kansas Medical Center, involving 27 ovarian cancer patients with grade 3 and grade 4 cancers, reported that IV vitamin C both enhanced the use of two drugs – carboplatin and paclitaxel – and showed fewer side effects from the toxicity of these drugs. Patients were monitored for five years and it was noted the patients “demonstrated a significant reduction in chemotherapy-induced adverse effects…”. [20]
Typical Duration of IV Vitamin C Therapy
Many alternative cancer care clinics begin with 8 to 12 sessions of IV vitamin C, often administered 2–3 times per week. A common starting regimen is 85 grams per infusion every 5 days for 8 rounds, which spans about 6 to 8 weeks.
Ongoing Maintenance: After the initial phase, some clinics recommend continuing IV vitamin C weekly or biweekly for several months or even indefinitely, depending on the patient’s progress and tolerance.
During Chemotherapy: Some integrative protocols combine IV vitamin C with chemotherapy, especially when conventional options offer limited benefit or when patients seek supportive care. In such cases, IV vitamin C may be administered throughout the chemotherapy cycle, often 2–3 times per week, and continued afterward depending on the patient’s response and tolerance.
Post-Chemotherapy Maintenance: After chemotherapy ends, clinics may recommend ongoing IV vitamin C infusions weekly or biweekly for several months. The goal is to support immune function, reduce inflammation, and potentially improve quality of life.
Long-Term Use: Some clinics suggest that lifelong or extended use of IV vitamin C may be beneficial for some patients, especially those with chronic conditions or metastatic disease. This is typically framed as part of a broader integrative strategy.
Monitoring and Adjustment: Treatment duration is highly individualized. Clinics often reassess every few weeks using lab markers (e.g., vitamin C plasma levels, tumor markers), imaging, and patient-reported outcomes to determine whether to continue, pause, or adjust the dosage.
IMPORTANT:
Do not self-administer intravenous vitamin C. You must work with a doctor (MD, integrative oncologist or naturopath) who is trained to administer the vitamin C in an intravenous drip because the human body keeps tight control over the allowable blood concentration of vitamin C, and it’s not possible to pump large concentrations up above a certain level through oral supplementation.
IV vitamin C may be contraindicated for those with kidney dysfunction or a history of kidney stones.
Because IV vitamin C treatments may cause inflammation, it is not recommended for those with inflammatory breast cancer. Nor is it recommended for cancer patients who are in a situation where even small amounts of inflammation or swelling would be dangerous.
References:
[1] High-dose vitamin C: A promising anti-tumor agent, insight from mechanisms, clinical research, and challenges – https://www.sciencedirect.com/science/article/pii/S2352304225002314#bib32
[2] Two Faces of Vitamin C—Antioxidative and Pro-Oxidative Agent – https://www.mdpi.com/2072-6643/12/5/1501
[3] Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis –
https://www.science.org/doi/10.1126/scitranslmed.3001127
[4] Cancer: a collagen disease, secondary to a nutritional deficiency – https://pubmed.ncbi.nlm.nih.gov/13638066/
[5] The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer – https://www.sciencedirect.com/science/article/abs/pii/0009279774900192
[6] Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer – https://www.pnas.org/doi/abs/10.1073/pnas.73.10.3685
[7] Failure of High-Dose Vitamin C (Ascorbic Acid) Therapy to Benefit Patients with Advanced Cancer — A Controlled Trial – https://www.nejm.org/doi/abs/10.1056/nejm197909273011303
[8] High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer Who Have Had No Prior Chemotherapy: A Randomized Double-Blind Comparison – https://www.scopus.com/pages/publications/0021955675?inward=
[9] Vitamin C Promotes Apoptosis and Cell Cycle Arrest in Oral Squamous Cell Carcinoma – https://pmc.ncbi.nlm.nih.gov/articles/PMC7298137/
[10] Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues – https://www.sciencedirect.com/science/article/pii/S2352304225002314#bib20
[11] Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2 – https://www.nature.com/articles/s41698-017-0044-8
[12] Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice – https://www.pnas.org/doi/full/10.1073/pnas.0804226105
[13] High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis – https://www.scopus.com/pages/publications/69349096333?inward
[14] Cytotoxicity of Ascorbic Acid in a Human Colorectal Adenocarcinoma Cell Line (WiDr): In Vitro and In Vivo Studies – https://www.tandfonline.com/doi/abs/10.1080/01635581.2012.713539
[15] Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects – https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011414
[16] Phase I clinical trial of i.v. ascorbic acid in advanced malignancy – https://www.annalsofoncology.org/article/S0923-7534(19)40136-1/fulltext
[17] Effects of High Doses of Vitamin C on Cancer Patients in Singapore: Nine Cases – https://journals.sagepub.com/doi/full/10.1177/1534735415622010
[18] Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer – https://link.springer.com/article/10.1007/s00280-013-2179-9
[19] Intravenous Vitamin C Administration Improves Quality of Life in Breast Cancer Patients during Chemo-/Radiotherapy and Aftercare: Results of a Retrospective, Multicentre, Epidemiological Cohort Study in Germany – https://iv.iiarjournals.org/content/25/6/983
[20] High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy – https://www.science.org/doi/abs/10.1126/scitranslmed.3007154
Article: Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach – https://pmc.ncbi.nlm.nih.gov/articles/PMC5927785/
Article: The Truth about Intravenous vitamin C (IVC) and cancer – https://www.canceractive.com/article/The-Truth-about-Intravenous-vitamin-C-(IVC)-and-cancer
About Marnie Clark
Hi I’m Marnie Clark, breast cancer survivor turned coach. I have 20 years of experience in natural medicine. In 2004/05 I battled breast cancer myself. You can see more about my journey on my page Breast Cancer Diary.
I’ve been healthy and recurrence-free since 2004 and in 2012 I became a Breast Cancer Coach because I became aware of the fact that whilst there is now a wealth of information on the Internet, much of it is confusing, conflicting, and sometimes just wrong!
So it is my duty to help you unconfuse and untangle all that information, and find what works for YOU.
GET MY BEST TIPS on healthy ways to beat breast cancer and prevent recurrences by signing up for my free e-newsletters and eBooks.
You can also “like” me on Facebook (Marnie Clark, Breast Health Coach) to get my inspirational snippets, news and updates. I promise to do my utmost to keep you informed and empowered on your healing journey… and beyond.
Subscribe On YouTube
Subscribe For Extra Support
Welcome to the Marnie Clark Breast Care Community. When you join my virtual family you will receive my informative newsletter PLUS my gift to you, these 2 eBooks valued at $47 to empower and support you on your breast cancer journey.
My subscribers also get a treasure trove of info on nutrition, supplements and lifestyle tips on surviving breast cancer.
“Thank you for the email and the meaningful words. I also wanted to thank you for being with me during my treatments. Your emails and posts not only gave me information but lots of courage.” Susan Z, Canada
0 Comments